Takhzyro 欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

takhzyro

takeda pharmaceuticals international ag ireland branch - lanadelumab - angioedem, ereditar - other hematological agents - takhzyro is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in patients aged 2 years and older.

TAKHZYRO 150 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

takhzyro 150 mg

takeda pharmaceuticals international ag ireland branch - irlanda - lanadelumabum - sol inj. in seringa preumpluta - 150mg - alti agenti hematologici medicamente utilizate in angioedemul ereditar

TAKHZYRO 300 mg 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

takhzyro 300 mg

shire pharmaceuticals ireland limited - irlanda - lanadelumabum - sol. inj. in seringa preumpluta - 300mg - medicamente utilizate in angioedemul ereditar medicamente utilizate in angioedemul ereditar